Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.
- NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_assertion description "[Although the anti-EGF receptor (EGFR) monoclonal antibody cetuximab is an effective strategy in colorectal cancer therapy, its clinical use is limited by intrinsic or acquired resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.
- NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_assertion evidence source_evidence_literature NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.
- NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_assertion SIO_000772 23166225 NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.
- NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_assertion wasDerivedFrom befree-20140225 NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.
- NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_assertion wasGeneratedBy ECO_0000203 NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP248024.RAtyk6P3Im3YEyhQwbDwRWluTM6hGH4zBhlGPKsk0WtGs130_provenance.